Biotech M&A – 2019 Deals

Biotech M&A With a Strong Start in 2019: More Deals to Follow?

Date Acquirer Co. Acquirer Ticker Acquired Co. Acquired Ticker Deal value Price/Share CVR (if any) Notes
01/03/2019 Bristol Myers BMY Celgen CELG $74B $102.43
$50 +1 BMY share
CVR $9.00 upon FDA approval of all 3 of ozanimod
01/07/201 Eli Lilly LLY Loxo Oncology LOXO $8B $235

 

For M&A 2018 full table click here https://www.chimeraresearchgroup.com/biotech-ma-2018-deals/